Cargando…
Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947601/ https://www.ncbi.nlm.nih.gov/pubmed/27288391 http://dx.doi.org/10.1136/annrheumdis-2013-204016corr1 |
_version_ | 1782443194184630272 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4947601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49476012016-07-28 Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study Ann Rheum Dis Electronic Pages BMJ Publishing Group 2016-07 /pmc/articles/PMC4947601/ /pubmed/27288391 http://dx.doi.org/10.1136/annrheumdis-2013-204016corr1 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ |
spellingShingle | Electronic Pages Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study |
title | Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study |
title_full | Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study |
title_fullStr | Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study |
title_full_unstemmed | Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study |
title_short | Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study |
title_sort | correction: discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the honor study |
topic | Electronic Pages |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947601/ https://www.ncbi.nlm.nih.gov/pubmed/27288391 http://dx.doi.org/10.1136/annrheumdis-2013-204016corr1 |